Cutaneous T-Cell Lymphoma CancerCare Connect Education Workshops

- Overview of Peripheral T-Cell Lymphoma (PTCL) - Types of Peripheral T-Cell Lymphoma - Current Standard of Care - New & Emerging Treatment Approaches - Treatments Under Investigation - Updates on Clinical Trials - How Clinical Trials Contribute to Your Treatment Options - Practical Tips to Manage Treatment Side Effects, Symptoms & Discomfort - Follow-Up Care - Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions and Discussion of

- Overview of Diffuse Large B-Cell Lymphoma (DLBCL), in the Context of COVID, Omicron & Seasonal Flu - Staging, Grading & Current Standard of Care - Treatment Options for Relapsed Refractory DLBCL - Bispecific Antibodies for Relapsed Refractory DLBCL - Understanding How Bispecific Antibodies Work in the Treatment of Relapsed Refractory DLBCL - New and Emerging Treatment Approaches - The Role of Clinical Trials - How Research Contributes to Treatment Choices - Tips to Manage Side Effects, Symptoms,

- Overview of Non-Hodgkin Lymphoma (NHL) - Signs & Symptoms, in the Context of COVID, Omicron & Seasonal Flu - NHL Staging & Subtypes - Indolent & Aggressive NHL - Relapsed & Refractory NHL - Novel Treatment Approaches - The Role of Clinical Trials: How Research Adds to Your Treatment Options - Your Comfort Level with Adherence - Managing Treatment Side Effects & Symptoms - Communicating with Your Health Care Team about Quality-of-Life Concerns - Follow-Up Care Appointments - Guidelines to Prepare

- Overview of Diffuse Large B-Cell Lymphoma, in the Context of COVID-19 & Omicron Variants - Staging & Grading - Current Standard of Care - Treatment Options for Resistant Disease - New and Emerging Treatment Approaches - The Role of Clinical Trials - How Research Contributes to Treatment Choices - Tips to Manage Side Effects, Symptoms, Discomfort & Pain - Key Questions to Ask Your Health Care Team about Quality-of-Life Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments,

- Overview of Marginal Zone Lymphoma (MZL), including Staging & Location, in the Context of COVID-19 - Subtypes of Marginal Zone Lymphoma - Review of Treatment Options - Treatment for Relapsed/Refractory Marginal Zone Lymphoma - Managing Treatment Side Effects, Symptoms & Discomfort - Key Questions to Ask Your Health Care Team - The Important Role of Clinical Trials, in the Context of COVID-19 - How Research Contributes to Your Treatment Options - The Increasing Role of Telehealth/Telemedicine

- Overview of Waldenstrom’s Macroglobulinemia, including Staging - Symptoms & Signs - Front Line Treatment for WM - Treatment for Relapsed/Refractory WM - Current Standard of Care & New Treatment Approaches - Translating Genomic Findings into New Treatment Opportunities for WM - Clinical Trials: How Research Contributes to Your Treatment Options - Controlling Symptoms & Treatment Side Effects, including Reducing Complications - Peripheral Neuropathy - Follow-Up Care Appointments & Plans -

- Update on the Treatment of Mantle Cell Lymphoma, in the Context of COVID-19 & Its Variants - Caring for Your Loved One with Mantle Cell Lymphoma, in the Context of COVID-19 & Its Variants - Challenges in Communicating with Your Health Care Team - Your Role in Adherence: Weekends, Holidays & Vacations - Coping with the Stresses of Caregiving When Your Loved One Has Mantle Cell Lymphoma (MCL) - Taking on the Role of Caregiving - Coping with Each Day, On Special Occasions, Anniversaries & Birthdays,

* Overview of Diffuse Large B-Cell Lymphoma, in the Context of COVID-19 * Staging & Grading * Current Standard of Care * Treatment Options for Resistant Disease * Emerging Treatment Approaches * Updates on Clinical Trials * How Research Contributes to Treatment Options * Tips to Manage Side Effects & Discomfort * Key Questions to Ask Your Health Care Team * Follow-Up Care: What to Expect * Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology & List of